ribavirin;1-((2R,3R,4S,5R)-3,4-DIHYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-1H-[1,2,4]TRIAZOLE-3-CARBOXYLIC ACID AMIDE;1-BETA-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE;1-BETA-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CAROXAMIDE;1-BETA-D-RIBOFURANOSYL-1H-1,2,4-TRIAZOLE-3-CARBOXAMIDE;biopolymers;D-RIBAVIRIN;ICN-1229;LEVOVIRIN;REBETOL;rtca;tribavirin;vilona;VIRAMID;VIRAZID;VIRAZOLE;ribamidyl;varazid;Ribavirine;1-(β-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide;1-beta-d-ribofuranosyl-2;1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide;1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide;4-triazole-3-carboxamide;Copegus;Ravanex;RTC;virazol;[ "" ];Ribaviri;Ribasphere;Ribamidil;Ribamide;Rebetron;Ribavirin Capsules;Ribavirinum;Ribavirina;Ribavirinum [INN-Latin];Ribavirine [INN-French];Ribavirina [INN-Spanish];SCH 18908;Ribavirin (Copegus);1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4;BRD-K60369935-001-02-7;D00423;Ribavirinum (INN-Latin);HMS3263E08;HMS2232P07;AB00430481;1-(beta -D-ribofuranosyl)-1,2,4-triazole-3-carboxamide;NCGC00090726-08;1-?-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide;GTPL6842;NSC163039;HMS3715G07;NCGC00090726-05;Rebretron;KBio1_000782;DTXSID8023557;NCGC00090726-09;BCP0726000138;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide;J05AP01;BPBio1_001195;SR-01000721904;cid_37542;CHEBI:63580;NSC 163039;Virazide;RIBAVIRIN COMPONENT OF PEGINTERFERON;KBioSS_002331;RIBAVIRIN [MART.];KBio2_004896;LP01063;SR-01000721904-2;BDBM50154375;1-Beta-D-ribofuranosyl-1,2,4-triazolo-3-carboxamide;Ribav;Tox21_110259;1-beta-Ribofuranosyl-1,2,4-triazole-3-carboamide;KBioGR_001804;DTXCID603557;R 9644;Rebetol (TN);RIBAVIRIN [MI];RIBAVIRIN [USAN];Ribavirin 100 microg/mL in Acetonitrile:Methanol;NCGC00090726-06;NCGC00258520-01;1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide;66510-90-5;Ribavirin Teva;Ribavirine (INN-French);MLS000028486;s2504;CAS-36791-04-5;Ribavirina (INN-Spanish);HMS2090L15;4pb1;SMP1_000261;AB00430481-16;RIBAVIRIN [EP MONOGRAPH];RIBAVIRIN (EP MONOGRAPH);NCGC00090726-03;Z594284196;1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide;1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide;Ribavirin, British Pharmacopoeia (BP) Reference Standard;RIBA;Ribavirin, United States Pharmacopeia (USP) Reference Standard;RBV;Spectrum_001826;1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-;UNII-49717AWG6K;Virazolee;Ribavirin, antiviral;Ribacine;KBio2_002328;BRD-K60369935-001-18-3;EN300-59237;Tox21_501063;Pharmakon1600-01503938;1-beta-d-ribofuranosyl-1h-1,2, 4-triazole-3-carboxamide;1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-;DB00811;36791-04-5;KBio2_007464;Ribavirin BioPartners;A823370;252269-50-4;SCH-18908;IWUCXVSUMQZMFG-AFCXAGJDSA-N;SBI-0051033.P003;Ro-20-9963;Ribavirin,(S);CCG-38985;Ribavirin (USAN:US...